Search

everythinglearnresearchcommunity

for

Search:↓

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Higher CRHR1 levels in AA patients lead to increased inflammation.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Upadacitinib improved multiple immune-related conditions in one patient.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

ACA from Alpinia galanga may prevent testosterone-related hair loss.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

5α-Reductase inhibitors can negatively impact sexual function.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

AH-001 could be a safer and more effective treatment for hair loss.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

Alefacept does not effectively treat severe alopecia areata.

CCL5 is important for the hair growth potential of human dermal papilla cells.

Caffeic acid helps protect rats from the harmful effects of acrylamide.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Activating Tgr5 may help treat hair loss and bone loss.

Acitretin helped improve hand mobility and skin condition in a patient.

5-Alpha-Reductase Inhibitors can cause negative side effects.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

Avicennia marina extract can significantly promote hair growth in androgenic alopecia patients.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.